2025 State of Digital Health Purchasing
By amorse
Purchasers remain committed to digital health but demand evidence of measurable outcomes. This survey reveals their priorities and future plans.
By amorse
Purchasers remain committed to digital health but demand evidence of measurable outcomes. This survey reveals their priorities and future plans.
By amorse
The 2025 PHTI Summit explored digital health’s evolution: employers demanding measurable outcomes, performance-based contracts rising, AI adoption accelerating, and industry maturing beyond engagement metrics.
By amorse
The Peterson Center on Healthcare’s report highlights opportunities to better align payment to value.
By amorse
PHTI research indicates that ambient scribes are potentially effective at reducing clinician documentation time and cognitive load.
By amorse
PHTI convened executives for an invitation-only summit that fostered conversation between those responsible for building, buying, and shaping digital health.
By amorse
While patients and purchasers have many priorities, delivering clinical benefit must be table stakes for a broader discussion about value.
By amorse
This new survey captures information about purchasers’ selection process, contracting approach, and future adoption plans.
By amorse
PHTI provided input to the American Medical Association’s (AMA) CPT Editorial Panel in response to its February 2024 meeting agenda. The meeting included Tab 50 – Remote Monitoring which included major revisions to remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM). PHTI’s Interested Party letter urged the AMA to delay consideration of this coding … Continued
By briteweb
This article appeared in HLTH on October 31, 2023 As HLTH 2023 reminded healthcare innovators, the digital technology world has ushered in an era of progress and promise featuring healthcare technologies that have the potential to improve health, expand access, and increase efficiency. Whether through apps that aim to address mental health needs, wearables that … Continued
By briteweb
This article appeared in LinkedIn Pulse on October 2, 2023 A Food and Drug Administration advisory panel’s decision to remove nasal decongestants containing phenylephrine from store shelves across the nation sent shockwaves across the healthcare spectrum. Phenylephrine, which is in more than 250 products worth nearly $1.8 billion in sales in 2022 and is used … Continued